Zobrazeno 1 - 10
of 37
pro vyhledávání: '"B M, Paterson"'
Autor:
R.S. Morris, Carola Sauter-Louis, B M Paterson, Dirk U. Pfeiffer, Leigh A. L. Corner, R. Jackson, Thibaud Porphyre
Publikováno v:
New Zealand Journal of Ecology. 43
Autor:
Jean-Francois Monty, Q. X. Li, Philip Doble, Paul S. Donnelly, David R. Kramer, A. I. Bush, James L. Hickey, B. J. Turner, J. F. B. Mercer, K. M. Kanninen, A. Grubman, Katherine A. Price, J. R. Williams, Lin W. Hung, C. L. Masters, R. M. Llanos, T. W. Rhoads, N. K. H. Lim, Dominic J. Hare, J. S. Beckman, Jeffrey R. Liddell, E. J. McAllum, Blaine R. Roberts, K. J. Barnham, J. A. Duce, B. M. Paterson, P. J. Crouch, S. C. Lim, A. R. White
Publikováno v:
Journal of Neurochemistry. 130:37-45
Autor:
Ciaran P. Kelly, Peter H.R. Green, L. A. Arterburn, Francisco León, B. M. Paterson, Joseph A. Murray, John Jiang, Richard N. Fedorak, Anthony J. DiMarino, Razvan Arsenescu, T. Alexander, Daniel A. Leffler, Anthony M. Colatrella
Publikováno v:
Alimentary Pharmacology & Therapeutics. 37:252-262
Summary Background Coeliac disease, an autoimmune disorder triggered by gluten ingestion, is managed by a gluten-free diet (GFD), which is difficult for many patients. Larazotide acetate is a first-in-class oral peptide that prevents tight junction o
Autor:
Joseph A. Murray, Anthony M. Colatrella, Francisco León, Z H Lan, B. M. Paterson, Daniel A. Leffler, H Z Abdallah, Lucinda A. Harris, L. A. Arterburn, Ciaran P. Kelly
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: In patients with celiac disease, enteropathy is caused by the entry of gluten peptides into the lamina propria of the intestine, in which their immunogenicity is potentiated by tissue transglutaminase (tTG) and T-helper type 1–mediated
Publikováno v:
Alimentary Pharmacology & Therapeutics. 26:757-766
Summary Background Lifelong adherence to a strict gluten-free diet is the cornerstone of coeliac disease treatment. Elucidation of disease pathogenesis has created opportunities for novel therapeutic approaches to coeliac disease. AT-1001 is an inhib
Autor:
B. Christ, Rudi Balling, Eva Bober, B. M. Paterson, Hans-Henning Arnold, C. Ebensperger, B. Brand-Saberi, J. Wilting
Publikováno v:
Europe PubMed Central
Formation of paraxial muscles in vertebrate embryos depends upon interactions between early somites and the neural tube and notochord. Removal of both axial struc-tures results in a complete loss of epaxial myotomal muscle, whereas hypaxial and limb
Publikováno v:
Genes & Development. 7:2456-2470
The myogenic regulatory factor MyoD dimerizes with other positive and negative regulatory factors through a conserved region called the helix-loop-helix (HLH) domain. Using a non-DNA-binding MyoD mutant with a normal HLH domain as a dimerization comp
Publikováno v:
Journal of Biological Chemistry. 268:24415-24420
MyoD is a member of the basic helix-loop-helix (bHLH) family of muscle gene regulatory proteins that includes myogenin, myf-5, and MRF4. These proteins have been shown to heterodimerize with E2A bHLH proteins, E12/E47, and to bind to a consensus sequ
Publikováno v:
Alimentary pharmacologytherapeutics. 26(5)
Lifelong adherence to a strict gluten-free diet is the cornerstone of coeliac disease treatment. Elucidation of disease pathogenesis has created opportunities for novel therapeutic approaches to coeliac disease. AT-1001 is an inhibitor of paracellula
Autor:
Richard N. Fedorak, B. M. Paterson, Joseph A. Murray, Razvan Arsenescu, L. A. Arterburn, Ciaran P. Kelly, Peter H.R. Green, Francisco León, T. Alexander, John Jiang, Anthony J. DiMarino, Anthony M. Colatrella, Daniel A. Leffler
Publikováno v:
Alimentary Pharmacology & Therapeutics. 37:496-497